UCLA Semel Institute
Welcome,         Profile    Billing    Logout  
 23 Trials 
9 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Leuchter, Andrew F
NCT04279522: The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Completed
N/A
126
US, RoW
Relivion®DP- Active, Relivion®DP- Sham
Neurolief Ltd.
MDD
06/24
06/24
ABT-CIP-10494, NCT06423430: Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Recruiting
N/A
100
US
Sham-stimulation, Active-stimulation
Abbott Medical Devices
Treatment Resistant Depression
04/27
04/29
Cook, Ian A
OLO, NCT05819021: Open Label Optimization Study

Recruiting
N/A
1000
US
SAINT® Neuromodulation System (NMS), TMS
Magnus Medical
Major Depressive Disorder
10/26
04/27
R
EMERALD, NCT05001737 / 2021-001577-24: Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE

Active, not recruiting
3
41
Europe, Canada, Japan, US, RoW
Emapalumab, NI-0501, emapalumab-lzsg, ATC code: L04AA39 (WHO)
Swedish Orphan Biovitrum
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease, Systemic Lupus Erythematosus, SJIA, AOSD, MAS
06/24
09/25
NCT06256003: Assessing Mobile Apps for Adult ADHD

Recruiting
N/A
140
US
UC-A, UC-N
Think Now Incorporated, University of California, Los Angeles, University of California, Berkeley
Attention Deficit Hyperactivity Disorder
08/24
10/24
NCT04296903: Post-approval Registry Study to Evaluate the Continued Safety and Probable Benefit of the MID-C System for 5 Years Post-Implantation in Adolescent Idiopathic Scoliosis (AIS)

Active, not recruiting
N/A
200
US
MID-C System
Apifix
Adolescent Idiopathic Scoliosis
06/29
06/30
Garcia, Consuelo
SYNAPSE-MG, NCT06414954: Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis

Recruiting
2
84
Europe, US, RoW
NMD670, Placebo
NMD Pharma A/S
Myasthenia Gravis, Myasthenia Gravis, MuSK
11/25
11/25
SYNAPSE-CMT, NCT06482437: Safety and Efficacy of NMD670 in Adult Patients With Type 1 and Type 2 Charcot-Marie-Tooth Disease

Recruiting
2
80
Europe, US
NMD670, Placebo
NMD Pharma A/S
Charcot-Marie-Tooth Disease
03/26
03/26
Brown, Robin
NCT05489588: The GORE® VIAFORT Vascular Stent Iliofemoral Study

Active, not recruiting
N/A
165
US
GORE® VIAFORT Vascular Stent
W.L.Gore & Associates
Venous Thromboses, Venous Disease, Venous Leg Ulcer, Venous Stasis, Venous Ulcer, Venous Stenosis, Venous Occlusion, Vein Thrombosis, Vein Occlusion, Vein Disease
04/25
04/29
Corlier, Juliana
No trials found
Dang, Bianca H
No trials found
NGO, THUC-DOAN
No trials found
Salimian, Anabel
No trials found

Download Options